Pharmacology and toxicology of the A(2A)-adenosine receptor agonist 2-[(cyclohexylmethylene)hydrazino]adenosine (MRE-0470) in the rat

Drug Development Research

Volumn 42, Issue 2, 1997, Pages 76-85

  Martin, Pauline L ^a   Barrett, R J ^a   Sykes, A ^a   Droppleman, D A ^a,b   Wright, K F ^a,b   Mossem, D ^a  

^a ADERIS Pharmaceuticals Inc   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adenosine agonist; Adenosine receptors; Blood pressure; Cardiovascular; Heart rate

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; BINODENOSON; GLYCERYL TRINITRATE; ISOPRENALINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BOLUS INJECTION; CARDIOMYOPATHY; CARDIOVASCULAR RESPONSE; CHRONOTROPISM; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; VAS DEFERENS;

EID: 0031447674     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199710)42:2<76::AID-DDR4>3.0.CO;2-M     Document Type: Article

References (18)

1. 1 receptors in vivo. Eur J Pharmacol 216:9-16.
2. 2 receptor subtype selectivity of adenosine receptor agonists in vivo. J Pharmacol Exp Ther 268:1166-1173.
3. Belin V, Hodge T, Picaut P, Jordan R, Algate C, Gosselin S, Nohynek G, Cavero I (1996): The myocardial lesions produced by the potassium channel opener aprikalim in monkeys and rats are prevented by blockade of cardiac beta-adrenoceptors. Fundam Appl Toxicol 31:259-267.
4. Church MK, Holgate ST (1993): Adenosine induced broncho-constriction and its inhibition by nedocromil sodium. J Allergy Clin Immunol 92:190-194.
5. 2 receptor function in rat ventricular myocytes. Cardiovasc Res 34:337-347.
6. 2 receptor stimulation. Ann NY Acad Sci 793:64-73.
7. 2B receptor evoke interleukin-8 secretion in human mast cells, an enprofyllne-sensitive mechanism with implications for asthma. J Clin Invest 96:1979-1986.
8. 2 receptor agonists in the pithed rat: No role for glibenclamide-sensitive potassium channels. Naunyn-Schmeideb Arch Pharmacol 347:192-196.
9. Glover DK, Ruiz M, Yang JY, Koplan BA, Allen R, Smith WH, Watson DD, Barrett RJ, Beller GA (1996): Pharmacological stress thallium scintigraphy with 2-cycohexylmethylidenehydrazinoadenosine (WRC-0470). Circulation 94:1726-1732.
10. 2 receptors in guinea pig aorta. J Pharmac Exp Ther 269:1228-1235.
11. 2 adenosine receptors in the aorta and coronary vessels from the guinea pig. J Pharmacol Exp Ther 265:248-253.
12. 2A receptor agonist that produces selective coronary vasodilation. Drug Dev Res 40:313-324.
13. Niiya K, Olsson RA, Thompson RD, Silvia RD, Ueeda M (1992): 2-(N′Alkylidenehydrazino)adenosines: Potent and selective coronary vasodilators. J Med Chem 35:4557-4561.
14. 2a selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102.
15. 3-adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 23:16887-16890.
16. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman NM (1997): Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 29:709-715.
17. 2-adenosine receptor agonists do not alter action potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat or rabbit isolated ventricular myocytes. Circ Res 72:194-205.
18. 2 agonists in the conscious spontaneously hypertensive rat: A comparative study of three structurally distinct ligands. J Pharmacol Exp Ther 259:1203-1212.